Company Search:
Advanced Search
Sponsored Links
Myungmoon Pharmaceutical Company Limited Company Snapshot
Myungmoon Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Myungmoon Pharmaceutical Company Limited with three other companies in this sector in South Korea: Whanin Pharmaceutical Company Limited (2017 sales of 147.95 billion Korean Won [US$138.19 million] ), Hyundai Pharmaceutical Company Limited (130.48 billion Korean Won [US$121.87 million] of which 88% was Pharmaceutical), and Dae Han New Pharm Co., Ltd. (130.82 billion Korean Won [US$122.18 million] ).

Sales Analysis. During the year ended December of 2017, sales at Myungmoon Pharmaceutical Company Limited were 140.14 billion Korean Won (US$130.89 million). This is a decrease of 1.4% versus 2016, when the company's sales were 142.18 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Myungmoon Pharmaceutical Company Limited
  Stock Performance Chart for Myungmoon Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 8,570.00
(Figures in Korean Won)
1 Week 4.1%   13 Weeks -10.7%  
4 Weeks 45.1%   52 Weeks 62.9%  
Myungmoon Pharmaceutical Company Limited Key Data:
  Ticker: 017180 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 140,137,942,908
(Year Ending Jan 2018).
Employees: 481
  Currency: Korean Won Market Cap: 209,095,507,871
  Fiscal Yr Ends: December Shares Outstanding: 24,398,542
  Share Type: Common Closely Held Shares: 6,410,599
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.